Herbas VPB

Print
EN | LT
LT - Pakeistieji nukleozidai, nukleotidai ir jų analogai
EN - SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07H 19/00 (2006.01)
C07H 19/06 (2006.01)
C07H 19/14 (2006.01)
C07H 19/16 (2006.01)
A61K 31/4184 (2006.01)
A61K 31/522 (2006.01)
A61K 31/506 (2006.01)
A61K 31/4192 (2006.01)
C07D 471/04 (2006.01)
C07D 473/34 (2006.01)
A61P 31/14 (2006.01)
C12N 9/99 (2006.01)
A61K 31/675 (2006.01)
A61K 31/708 (2006.01)
A61K 31/7068 (2006.01)
A61K 31/7072 (2006.01)
European patent
(11) Number of the document 2794627
(13) Kind of document T
(96) European patent application number 12860391.7
Date of filing the European patent application 2012-12-20
(97) Date of publication of the European application 2014-10-29
(45) Date of publication and mention of the grant of the patent 2018-09-26
(46) Date of publication of the claims translation 2019-01-10
PCT application
(86) Number PCT/US2012/071063
Date 2012-12-20
PCT application publication
(87) Number WO 2013/096679
Date 2013-06-27
Priority applications
(30) Number Date Country code
201161579560 P 2011-12-22 US
201261613836 P 2012-03-21 US
Inventors
(72)
BEIGELMAN, Leonid, US
WANG, Guangyi, US
SMITH, David, Bernard, US
DEVAL, Jerome, US
PRHAVC, Marija, US
Grantee
(73) Jannsen BioPharma, Inc., 260-E Grand Avenue, 2nd Floor, South San Francisco, CA 94080, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Title
(54) Pakeistieji nukleozidai, nukleotidai ir jų analogai
  SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
Last renewal fee
Payment date Validity (years) Amount
2021-11-24 10 231.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2022-12-20